Sara Sawyer
Concepts (604)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Primates | 19 | 2024 | 133 | 3.740 |
Why?
| | Evolution, Molecular | 17 | 2021 | 492 | 3.730 |
Why?
| | Dengue Virus | 4 | 2026 | 60 | 3.030 |
Why?
| | HIV-1 | 13 | 2026 | 908 | 2.930 |
Why?
| | CD4 Antigens | 7 | 2026 | 137 | 2.810 |
Why?
| | Virus Replication | 16 | 2026 | 521 | 2.800 |
Why?
| | Selection, Genetic | 18 | 2021 | 261 | 2.520 |
Why?
| | Viruses | 6 | 2023 | 165 | 2.360 |
Why?
| | Saliva | 4 | 2026 | 246 | 2.260 |
Why?
| | Exome | 13 | 2025 | 227 | 2.140 |
Why?
| | Dengue | 4 | 2026 | 91 | 1.950 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 3 | 2025 | 92 | 1.900 |
Why?
| | Pan troglodytes | 5 | 2025 | 62 | 1.830 |
Why?
| | Genetic Testing | 14 | 2026 | 480 | 1.820 |
Why?
| | Mutation | 27 | 2023 | 4075 | 1.720 |
Why?
| | Aotidae | 4 | 2026 | 10 | 1.580 |
Why?
| | Simian Immunodeficiency Virus | 3 | 2025 | 93 | 1.540 |
Why?
| | Host-Pathogen Interactions | 9 | 2021 | 361 | 1.520 |
Why?
| | Rare Diseases | 8 | 2025 | 116 | 1.480 |
Why?
| | RNA, Viral | 6 | 2026 | 692 | 1.390 |
Why?
| | Carrier Proteins | 11 | 2017 | 728 | 1.370 |
Why?
| | Ubiquitin-Protein Ligases | 10 | 2019 | 192 | 1.370 |
Why?
| | Nuclear Proteins | 10 | 2020 | 740 | 1.360 |
Why?
| | Sequence Analysis, DNA | 12 | 2025 | 777 | 1.300 |
Why?
| | Carrier State | 2 | 2021 | 78 | 1.280 |
Why?
| | Viral Proteins | 7 | 2021 | 350 | 1.260 |
Why?
| | Intellectual Disability | 10 | 2025 | 179 | 1.240 |
Why?
| | Host Specificity | 5 | 2018 | 33 | 1.230 |
Why?
| | Receptors, Virus | 6 | 2019 | 95 | 1.220 |
Why?
| | Zoonoses | 3 | 2019 | 38 | 1.200 |
Why?
| | Animals | 59 | 2026 | 38030 | 1.160 |
Why?
| | HIV Infections | 10 | 2026 | 3193 | 1.080 |
Why?
| | Nuclear Pore Complex Proteins | 2 | 2018 | 40 | 1.070 |
Why?
| | Genes, BRCA1 | 5 | 2015 | 45 | 1.070 |
Why?
| | Genomics | 9 | 2026 | 825 | 1.060 |
Why?
| | Saccharomyces cerevisiae | 6 | 2018 | 573 | 1.020 |
Why?
| | Virology | 2 | 2024 | 36 | 0.990 |
Why?
| | Tripartite Motif Proteins | 7 | 2019 | 39 | 0.980 |
Why?
| | Genome | 3 | 2024 | 305 | 0.960 |
Why?
| | Receptors, Transferrin | 3 | 2015 | 28 | 0.940 |
Why?
| | Receptors, CXCR4 | 2 | 2026 | 91 | 0.940 |
Why?
| | Chiroptera | 3 | 2019 | 59 | 0.920 |
Why?
| | Reverse Genetics | 1 | 2025 | 7 | 0.900 |
Why?
| | Gorilla gorilla | 1 | 2025 | 17 | 0.900 |
Why?
| | Flaviviridae | 1 | 2025 | 10 | 0.890 |
Why?
| | Influenza A Virus, H3N2 Subtype | 2 | 2023 | 50 | 0.880 |
Why?
| | Virus Internalization | 5 | 2022 | 65 | 0.870 |
Why?
| | Biological Evolution | 7 | 2024 | 467 | 0.860 |
Why?
| | Amino Acid Sequence | 20 | 2019 | 2129 | 0.860 |
Why?
| | Humans | 113 | 2026 | 145474 | 0.860 |
Why?
| | Viral Tropism | 3 | 2026 | 36 | 0.830 |
Why?
| | High-Throughput Nucleotide Sequencing | 9 | 2025 | 530 | 0.820 |
Why?
| | Whole Genome Sequencing | 4 | 2025 | 177 | 0.810 |
Why?
| | Saccharomyces cerevisiae Proteins | 6 | 2018 | 414 | 0.810 |
Why?
| | Polymorphism, Single Nucleotide | 14 | 2019 | 2158 | 0.800 |
Why?
| | Orthomyxoviridae | 1 | 2024 | 40 | 0.800 |
Why?
| | Peptide Hydrolases | 3 | 2020 | 105 | 0.790 |
Why?
| | Influenza in Birds | 1 | 2023 | 5 | 0.780 |
Why?
| | Repressor Proteins | 7 | 2023 | 429 | 0.780 |
Why?
| | Retroelements | 2 | 2018 | 50 | 0.780 |
Why?
| | Hemorrhagic Fevers, Viral | 1 | 2022 | 16 | 0.740 |
Why?
| | Epidemiological Monitoring | 1 | 2023 | 69 | 0.740 |
Why?
| | Genetic Diseases, Inborn | 3 | 2023 | 45 | 0.740 |
Why?
| | Arterivirus | 1 | 2022 | 18 | 0.740 |
Why?
| | Dog Diseases | 2 | 2023 | 86 | 0.730 |
Why?
| | Neurofibromatosis 1 | 1 | 2023 | 55 | 0.730 |
Why?
| | Cell Cycle Proteins | 5 | 2016 | 630 | 0.730 |
Why?
| | Virus Diseases | 2 | 2016 | 216 | 0.720 |
Why?
| | Rhabdomyosarcoma | 1 | 2023 | 65 | 0.720 |
Why?
| | Phylogeny | 12 | 2019 | 917 | 0.700 |
Why?
| | Homozygote | 3 | 2021 | 199 | 0.690 |
Why?
| | Genetic Variation | 8 | 2018 | 972 | 0.690 |
Why?
| | RNA, Messenger | 5 | 2023 | 2803 | 0.670 |
Why?
| | Mammals | 5 | 2024 | 286 | 0.660 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 273 | 0.650 |
Why?
| | Cell Line | 11 | 2025 | 2823 | 0.650 |
Why?
| | Molecular Sequence Data | 18 | 2015 | 2883 | 0.650 |
Why?
| | Urogenital Abnormalities | 1 | 2021 | 71 | 0.640 |
Why?
| | Wnt Proteins | 1 | 2021 | 133 | 0.630 |
Why?
| | Congenital Abnormalities | 1 | 2021 | 109 | 0.630 |
Why?
| | Interferon Type I | 1 | 2021 | 147 | 0.620 |
Why?
| | Herpesvirus 1, Human | 3 | 2018 | 84 | 0.610 |
Why?
| | Species Specificity | 9 | 2018 | 546 | 0.600 |
Why?
| | Soft Tissue Neoplasms | 2 | 2018 | 131 | 0.590 |
Why?
| | Computational Biology | 7 | 2020 | 669 | 0.590 |
Why?
| | Membrane Proteins | 3 | 2018 | 1164 | 0.580 |
Why?
| | Virus Attachment | 2 | 2015 | 19 | 0.580 |
Why?
| | Genome, Viral | 3 | 2025 | 214 | 0.570 |
Why?
| | Polysaccharides | 1 | 2019 | 86 | 0.570 |
Why?
| | DNA-Binding Proteins | 8 | 2021 | 1480 | 0.570 |
Why?
| | Genes, BRCA2 | 4 | 2015 | 33 | 0.560 |
Why?
| | Arenaviruses, New World | 2 | 2015 | 9 | 0.560 |
Why?
| | Genes | 2 | 2015 | 227 | 0.550 |
Why?
| | HEK293 Cells | 7 | 2024 | 741 | 0.550 |
Why?
| | Transcription Factors | 4 | 2023 | 1734 | 0.540 |
Why?
| | Base Sequence | 12 | 2024 | 2170 | 0.540 |
Why?
| | Hamartoma Syndrome, Multiple | 1 | 2017 | 16 | 0.530 |
Why?
| | Leukoencephalopathies | 1 | 2017 | 24 | 0.530 |
Why?
| | Circulating Tumor DNA | 3 | 2022 | 46 | 0.520 |
Why?
| | Genetic Predisposition to Disease | 12 | 2025 | 2378 | 0.510 |
Why?
| | BRCA1 Protein | 2 | 2014 | 82 | 0.510 |
Why?
| | Genome, Human | 9 | 2025 | 420 | 0.510 |
Why?
| | DNA, Circular | 2 | 2014 | 15 | 0.510 |
Why?
| | Fibroma | 1 | 2017 | 21 | 0.510 |
Why?
| | Kidney Diseases | 1 | 2021 | 425 | 0.500 |
Why?
| | Ribonucleoproteins | 1 | 2017 | 89 | 0.500 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 664 | 0.490 |
Why?
| | DNA Repair Enzymes | 1 | 2016 | 29 | 0.480 |
Why?
| | Immediate-Early Proteins | 1 | 2016 | 46 | 0.480 |
Why?
| | Models, Biological | 1 | 2024 | 1764 | 0.480 |
Why?
| | PTEN Phosphohydrolase | 1 | 2017 | 165 | 0.480 |
Why?
| | Influenza A virus | 4 | 2023 | 119 | 0.480 |
Why?
| | Molecular Chaperones | 1 | 2018 | 199 | 0.470 |
Why?
| | Exoribonucleases | 1 | 2016 | 43 | 0.470 |
Why?
| | Neurodevelopmental Disorders | 4 | 2024 | 227 | 0.470 |
Why?
| | Kidney | 2 | 2021 | 1497 | 0.470 |
Why?
| | Macrophages | 1 | 2024 | 1507 | 0.470 |
Why?
| | Virus Physiological Phenomena | 2 | 2012 | 9 | 0.460 |
Why?
| | Lipomatosis, Multiple Symmetrical | 1 | 2015 | 1 | 0.460 |
Why?
| | Host-Parasite Interactions | 1 | 2016 | 110 | 0.450 |
Why?
| | Dogs | 5 | 2023 | 458 | 0.440 |
Why?
| | Abnormalities, Multiple | 4 | 2024 | 199 | 0.440 |
Why?
| | Fanconi Anemia | 1 | 2014 | 11 | 0.440 |
Why?
| | GTP Phosphohydrolases | 1 | 2015 | 93 | 0.430 |
Why?
| | Fungal Proteins | 3 | 2006 | 143 | 0.430 |
Why?
| | Histones | 2 | 2017 | 666 | 0.430 |
Why?
| | Breast Neoplasms | 6 | 2015 | 2382 | 0.420 |
Why?
| | Multigene Family | 2 | 2013 | 210 | 0.420 |
Why?
| | Recombination, Genetic | 3 | 2013 | 203 | 0.420 |
Why?
| | Retroviridae | 5 | 2011 | 100 | 0.420 |
Why?
| | Embryonic Development | 1 | 2015 | 125 | 0.420 |
Why?
| | Developmental Disabilities | 5 | 2025 | 281 | 0.410 |
Why?
| | DNA Repair | 3 | 2014 | 254 | 0.410 |
Why?
| | Polymorphism, Genetic | 6 | 2014 | 614 | 0.410 |
Why?
| | BRCA2 Protein | 1 | 2014 | 68 | 0.410 |
Why?
| | Cerebellar Ataxia | 1 | 2014 | 13 | 0.410 |
Why?
| | Child | 26 | 2026 | 22707 | 0.410 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2022 | 56 | 0.400 |
Why?
| | Ranavirus | 1 | 2013 | 6 | 0.390 |
Why?
| | Research Design | 5 | 2026 | 1137 | 0.390 |
Why?
| | Cutis Laxa | 1 | 2013 | 2 | 0.390 |
Why?
| | Genes, Essential | 1 | 2013 | 19 | 0.390 |
Why?
| | Proteins | 3 | 2016 | 1023 | 0.390 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2015 | 231 | 0.390 |
Why?
| | Elastic Tissue | 1 | 2013 | 10 | 0.390 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 263 | 0.380 |
Why?
| | Ovarian Neoplasms | 5 | 2022 | 595 | 0.380 |
Why?
| | Exons | 4 | 2024 | 363 | 0.370 |
Why?
| | Genome, Fungal | 2 | 2018 | 44 | 0.370 |
Why?
| | Transcriptome | 1 | 2019 | 1038 | 0.370 |
Why?
| | Antigens, CD | 1 | 2015 | 558 | 0.360 |
Why?
| | Nervous System Diseases | 1 | 2015 | 286 | 0.360 |
Why?
| | Plasmodium knowlesi | 1 | 2011 | 1 | 0.350 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2018 | 387 | 0.350 |
Why?
| | Duffy Blood-Group System | 1 | 2011 | 5 | 0.350 |
Why?
| | Extracellular Matrix Proteins | 1 | 2013 | 156 | 0.350 |
Why?
| | Plasmodium vivax | 1 | 2011 | 6 | 0.350 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1454 | 0.350 |
Why?
| | Influenza, Human | 1 | 2017 | 624 | 0.340 |
Why?
| | Gene Frequency | 5 | 2011 | 487 | 0.340 |
Why?
| | Phenotype | 10 | 2023 | 3155 | 0.340 |
Why?
| | DNA, Viral | 1 | 2013 | 356 | 0.340 |
Why?
| | Flow Cytometry | 3 | 2024 | 1162 | 0.330 |
Why?
| | Ontario | 6 | 2026 | 90 | 0.310 |
Why?
| | Receptors, Cell Surface | 2 | 2011 | 372 | 0.300 |
Why?
| | Models, Molecular | 5 | 2017 | 1598 | 0.300 |
Why?
| | Protein Binding | 8 | 2019 | 2238 | 0.300 |
Why?
| | Child, Preschool | 17 | 2025 | 11853 | 0.290 |
Why?
| | Growth Disorders | 2 | 2020 | 89 | 0.290 |
Why?
| | Canada | 4 | 2025 | 431 | 0.290 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2011 | 425 | 0.280 |
Why?
| | Mutation, Missense | 4 | 2023 | 335 | 0.280 |
Why?
| | Female | 35 | 2026 | 78844 | 0.280 |
Why?
| | Microcephaly | 2 | 2020 | 104 | 0.280 |
Why?
| | Facies | 4 | 2023 | 22 | 0.270 |
Why?
| | Alleles | 5 | 2014 | 894 | 0.270 |
Why?
| | Sequence Alignment | 4 | 2019 | 362 | 0.270 |
Why?
| | A549 Cells | 2 | 2018 | 75 | 0.270 |
Why?
| | Epidemics | 2 | 2019 | 96 | 0.260 |
Why?
| | Gene Duplication | 2 | 2021 | 66 | 0.260 |
Why?
| | Polymerase Chain Reaction | 4 | 2016 | 1041 | 0.250 |
Why?
| | Molecular Diagnostic Techniques | 2 | 2021 | 103 | 0.250 |
Why?
| | DNA Transposable Elements | 2 | 2024 | 124 | 0.250 |
Why?
| | Saccharomyces | 1 | 2006 | 6 | 0.250 |
Why?
| | Germ-Line Mutation | 4 | 2023 | 176 | 0.250 |
Why?
| | Infant | 11 | 2025 | 10077 | 0.240 |
Why?
| | Viral Load | 2 | 2021 | 526 | 0.240 |
Why?
| | Haplotypes | 2 | 2005 | 499 | 0.240 |
Why?
| | Immunocompetence | 1 | 2026 | 46 | 0.240 |
Why?
| | Epilepsy | 2 | 2025 | 390 | 0.230 |
Why?
| | Protein Structure, Tertiary | 6 | 2012 | 855 | 0.230 |
Why?
| | Genotype | 6 | 2015 | 1852 | 0.230 |
Why?
| | Erythrocytes | 1 | 2011 | 748 | 0.220 |
Why?
| | Genetics, Medical | 1 | 2025 | 23 | 0.220 |
Why?
| | Culicidae | 1 | 2025 | 33 | 0.220 |
Why?
| | Replication Origin | 2 | 2004 | 18 | 0.220 |
Why?
| | Viremia | 1 | 2026 | 160 | 0.220 |
Why?
| | Male | 24 | 2026 | 72842 | 0.220 |
Why?
| | Genes, Viral | 4 | 2013 | 88 | 0.220 |
Why?
| | Nucleoside Deaminases | 1 | 2004 | 2 | 0.210 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2024 | 35 | 0.210 |
Why?
| | Aedes | 1 | 2025 | 66 | 0.210 |
Why?
| | Linkage Disequilibrium | 1 | 2005 | 253 | 0.210 |
Why?
| | Neoplasms | 2 | 2022 | 2906 | 0.210 |
Why?
| | Endogenous Retroviruses | 1 | 2005 | 37 | 0.210 |
Why?
| | DNA | 3 | 2004 | 1435 | 0.210 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2024 | 14 | 0.210 |
Why?
| | Adult | 14 | 2026 | 40777 | 0.210 |
Why?
| | Nucleic Acid Hybridization | 2 | 2003 | 187 | 0.200 |
Why?
| | Carcinogenesis | 2 | 2016 | 228 | 0.200 |
Why?
| | Bone Diseases, Developmental | 1 | 2023 | 16 | 0.200 |
Why?
| | Tooth Abnormalities | 1 | 2023 | 16 | 0.200 |
Why?
| | Codon, Terminator | 1 | 2003 | 25 | 0.200 |
Why?
| | Signal Transduction | 5 | 2024 | 5216 | 0.200 |
Why?
| | Megalencephaly | 1 | 2023 | 20 | 0.200 |
Why?
| | Virion | 2 | 2021 | 108 | 0.200 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2016 | 145 | 0.200 |
Why?
| | Algorithms | 2 | 2025 | 1845 | 0.190 |
Why?
| | Cafe-au-Lait Spots | 1 | 2023 | 3 | 0.190 |
Why?
| | Vaginal Neoplasms | 1 | 2023 | 19 | 0.190 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2024 | 108 | 0.190 |
Why?
| | HIV | 1 | 2004 | 251 | 0.190 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2023 | 117 | 0.190 |
Why?
| | Triage | 1 | 2025 | 250 | 0.190 |
Why?
| | Macaca | 1 | 2022 | 66 | 0.190 |
Why?
| | Mutagenesis, Insertional | 2 | 2018 | 67 | 0.180 |
Why?
| | Birds | 1 | 2023 | 86 | 0.180 |
Why?
| | Alternative Splicing | 1 | 2024 | 247 | 0.180 |
Why?
| | Orthomyxoviridae Infections | 1 | 2023 | 71 | 0.180 |
Why?
| | Oligonucleotides | 1 | 2003 | 153 | 0.180 |
Why?
| | RNA Viruses | 2 | 2019 | 73 | 0.180 |
Why?
| | Mice | 10 | 2021 | 18329 | 0.180 |
Why?
| | Disease Models, Animal | 2 | 2026 | 4560 | 0.180 |
Why?
| | Biomarkers | 2 | 2024 | 4295 | 0.180 |
Why?
| | Universities | 2 | 2023 | 445 | 0.180 |
Why?
| | Alzheimer Disease | 3 | 2003 | 630 | 0.180 |
Why?
| | DNA Methylation | 2 | 2024 | 674 | 0.180 |
Why?
| | Wilms Tumor | 1 | 2023 | 89 | 0.170 |
Why?
| | Interferons | 2 | 2024 | 186 | 0.170 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 39 | 0.170 |
Why?
| | Asymptomatic Infections | 1 | 2021 | 37 | 0.170 |
Why?
| | Pedigree | 4 | 2017 | 515 | 0.170 |
Why?
| | Urinary Tract | 1 | 2021 | 47 | 0.170 |
Why?
| | Monocytes | 1 | 2024 | 539 | 0.170 |
Why?
| | Viral Nonstructural Proteins | 2 | 2020 | 63 | 0.160 |
Why?
| | Genome-Wide Association Study | 3 | 2019 | 1407 | 0.160 |
Why?
| | Gene Expression Profiling | 2 | 2024 | 1767 | 0.160 |
Why?
| | Glycosylation | 2 | 2019 | 173 | 0.160 |
Why?
| | Ubiquitination | 2 | 2019 | 118 | 0.160 |
Why?
| | Macaca mulatta | 2 | 2019 | 186 | 0.160 |
Why?
| | Chromosome Disorders | 1 | 2021 | 47 | 0.160 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2021 | 80 | 0.160 |
Why?
| | Chromosomes, Human, X | 1 | 2021 | 77 | 0.160 |
Why?
| | Kidney Tubules | 1 | 2021 | 118 | 0.160 |
Why?
| | Acute Disease | 1 | 2023 | 1036 | 0.160 |
Why?
| | Blepharophimosis | 1 | 2020 | 4 | 0.160 |
Why?
| | Fibroblasts | 2 | 2024 | 1025 | 0.160 |
Why?
| | Databases, Genetic | 3 | 2014 | 238 | 0.160 |
Why?
| | Crowdsourcing | 1 | 2020 | 18 | 0.160 |
Why?
| | Eczema | 1 | 2020 | 66 | 0.160 |
Why?
| | Receptors, CCR5 | 2 | 2017 | 60 | 0.150 |
Why?
| | DNA Primers | 2 | 2015 | 505 | 0.150 |
Why?
| | RNA Virus Infections | 1 | 2019 | 19 | 0.150 |
Why?
| | Pandemics | 3 | 2023 | 1707 | 0.150 |
Why?
| | RNA, Double-Stranded | 1 | 2019 | 51 | 0.150 |
Why?
| | Flavivirus Infections | 1 | 2019 | 9 | 0.150 |
Why?
| | Models, Genetic | 4 | 2006 | 524 | 0.150 |
Why?
| | env Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 15 | 0.150 |
Why?
| | Specimen Handling | 1 | 2021 | 182 | 0.150 |
Why?
| | DNA Helicases | 1 | 2000 | 136 | 0.150 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2019 | 55 | 0.150 |
Why?
| | Cytidine Deaminase | 2 | 2013 | 59 | 0.140 |
Why?
| | Histone Deacetylases | 1 | 2020 | 207 | 0.140 |
Why?
| | Viral Structural Proteins | 1 | 2018 | 12 | 0.140 |
Why?
| | Observational Studies as Topic | 3 | 2026 | 133 | 0.140 |
Why?
| | Myofibromatosis | 1 | 2018 | 10 | 0.140 |
Why?
| | Decision Making | 1 | 2026 | 977 | 0.140 |
Why?
| | HIV Seropositivity | 1 | 2019 | 119 | 0.140 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 31 | 0.140 |
Why?
| | Nucleotidyltransferases | 1 | 2018 | 29 | 0.140 |
Why?
| | Alopecia | 1 | 2018 | 37 | 0.140 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2019 | 82 | 0.140 |
Why?
| | Longitudinal Studies | 1 | 2026 | 2953 | 0.140 |
Why?
| | Kidney Neoplasms | 1 | 2023 | 413 | 0.140 |
Why?
| | Sequence Homology | 1 | 2018 | 43 | 0.140 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2019 | 155 | 0.140 |
Why?
| | DEAD Box Protein 58 | 1 | 2017 | 7 | 0.130 |
Why?
| | DNA, Fungal | 1 | 2018 | 76 | 0.130 |
Why?
| | SUMO-1 Protein | 1 | 2017 | 18 | 0.130 |
Why?
| | Africa | 1 | 2018 | 119 | 0.130 |
Why?
| | Adolescent | 11 | 2025 | 22529 | 0.130 |
Why?
| | Cost-Benefit Analysis | 3 | 2025 | 639 | 0.130 |
Why?
| | Acetyltransferases | 1 | 2017 | 27 | 0.130 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2019 | 159 | 0.130 |
Why?
| | Charcot-Marie-Tooth Disease | 1 | 2017 | 22 | 0.130 |
Why?
| | Parents | 1 | 2026 | 1403 | 0.130 |
Why?
| | Pathology, Molecular | 1 | 2017 | 25 | 0.130 |
Why?
| | Intelligence | 1 | 2017 | 113 | 0.130 |
Why?
| | Callithrix | 1 | 2016 | 10 | 0.130 |
Why?
| | Hylobates | 1 | 2016 | 8 | 0.130 |
Why?
| | Membrane Transport Proteins | 1 | 2018 | 154 | 0.130 |
Why?
| | Pongo | 1 | 2016 | 7 | 0.130 |
Why?
| | Electronic Health Records | 1 | 2025 | 1196 | 0.130 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 447 | 0.130 |
Why?
| | Totivirus | 1 | 2016 | 1 | 0.120 |
Why?
| | Infant, Newborn | 4 | 2018 | 6447 | 0.120 |
Why?
| | Chondroblastoma | 1 | 2016 | 3 | 0.120 |
Why?
| | Brachydactyly | 1 | 2016 | 2 | 0.120 |
Why?
| | Prospective Studies | 6 | 2026 | 8057 | 0.120 |
Why?
| | Dysarthria | 1 | 2016 | 10 | 0.120 |
Why?
| | Spinocerebellar Ataxias | 1 | 2016 | 6 | 0.120 |
Why?
| | Genetic Association Studies | 2 | 2015 | 369 | 0.120 |
Why?
| | Receptors, Immunologic | 1 | 2017 | 208 | 0.120 |
Why?
| | Immunoprecipitation | 1 | 2016 | 148 | 0.120 |
Why?
| | Behavior Therapy | 1 | 2019 | 296 | 0.120 |
Why?
| | Immunoblotting | 1 | 2016 | 295 | 0.120 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2016 | 12 | 0.120 |
Why?
| | Young Adult | 7 | 2021 | 14218 | 0.120 |
Why?
| | Capsid | 3 | 2012 | 94 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1997 | 0.120 |
Why?
| | Autism Spectrum Disorder | 2 | 2021 | 422 | 0.120 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 2015 | 18 | 0.120 |
Why?
| | Protein Interaction Mapping | 1 | 2016 | 105 | 0.120 |
Why?
| | Cell Differentiation | 1 | 2024 | 2046 | 0.120 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2016 | 376 | 0.120 |
Why?
| | Immunity, Innate | 3 | 2024 | 835 | 0.110 |
Why?
| | Filoviridae | 1 | 2015 | 27 | 0.110 |
Why?
| | White Matter | 1 | 2017 | 153 | 0.110 |
Why?
| | Disease Resistance | 1 | 2015 | 29 | 0.110 |
Why?
| | Antiviral Agents | 2 | 2021 | 769 | 0.110 |
Why?
| | Muscle Spasticity | 1 | 2016 | 63 | 0.110 |
Why?
| | Activin Receptors, Type I | 1 | 2015 | 6 | 0.110 |
Why?
| | Myositis Ossificans | 1 | 2015 | 4 | 0.110 |
Why?
| | Heat-Shock Proteins | 1 | 2016 | 139 | 0.110 |
Why?
| | Hallux Valgus | 1 | 2015 | 8 | 0.110 |
Why?
| | Tuberculosis | 1 | 2018 | 283 | 0.110 |
Why?
| | Neanderthals | 1 | 2015 | 13 | 0.110 |
Why?
| | Molecular Docking Simulation | 1 | 2015 | 119 | 0.110 |
Why?
| | Blotting, Western | 2 | 2016 | 1179 | 0.110 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2014 | 6 | 0.110 |
Why?
| | Gene Expression | 2 | 2011 | 1476 | 0.110 |
Why?
| | Extinction, Biological | 1 | 2015 | 33 | 0.110 |
Why?
| | Vesicle-Associated Membrane Protein 1 | 1 | 2014 | 2 | 0.110 |
Why?
| | Craniofacial Abnormalities | 1 | 2015 | 78 | 0.110 |
Why?
| | Acclimatization | 1 | 2016 | 170 | 0.110 |
Why?
| | Transfection | 1 | 2016 | 926 | 0.110 |
Why?
| | HIV-2 | 1 | 2014 | 18 | 0.110 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 207 | 0.110 |
Why?
| | Colorado | 2 | 2023 | 4553 | 0.110 |
Why?
| | Siblings | 1 | 2015 | 196 | 0.110 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2014 | 15 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 456 | 0.100 |
Why?
| | Morphogenesis | 1 | 2015 | 172 | 0.100 |
Why?
| | Syndrome | 1 | 2015 | 381 | 0.100 |
Why?
| | Gene Rearrangement | 1 | 2015 | 155 | 0.100 |
Why?
| | Ribosomes | 1 | 2015 | 193 | 0.100 |
Why?
| | Hemiplegia | 1 | 2014 | 20 | 0.100 |
Why?
| | Chromosome Mapping | 3 | 2005 | 506 | 0.100 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2015 | 107 | 0.100 |
Why?
| | Consanguinity | 1 | 2014 | 49 | 0.100 |
Why?
| | Dystonic Disorders | 1 | 2014 | 27 | 0.100 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 55 | 0.100 |
Why?
| | Peer Review, Research | 1 | 2014 | 36 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 2 | 2017 | 3904 | 0.100 |
Why?
| | Botulinum Toxins | 1 | 2014 | 48 | 0.100 |
Why?
| | Bone Neoplasms | 1 | 2016 | 259 | 0.100 |
Why?
| | Sarcoma | 1 | 2016 | 207 | 0.100 |
Why?
| | Gene Library | 1 | 2013 | 122 | 0.100 |
Why?
| | Chromosomal Proteins, Non-Histone | 3 | 2004 | 130 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 866 | 0.100 |
Why?
| | Adaptation, Biological | 1 | 2013 | 48 | 0.100 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 499 | 0.090 |
Why?
| | Nervous System Malformations | 1 | 2013 | 46 | 0.090 |
Why?
| | Amphibians | 1 | 2013 | 55 | 0.090 |
Why?
| | Middle Aged | 6 | 2025 | 36215 | 0.090 |
Why?
| | Parvovirus, Canine | 1 | 2012 | 1 | 0.090 |
Why?
| | Canidae | 1 | 2012 | 1 | 0.090 |
Why?
| | Parvoviridae Infections | 1 | 2012 | 12 | 0.090 |
Why?
| | Mass Screening | 1 | 2021 | 1360 | 0.090 |
Why?
| | Brain | 3 | 2015 | 2947 | 0.090 |
Why?
| | DNA Mutational Analysis | 4 | 2014 | 407 | 0.090 |
Why?
| | Neoplastic Stem Cells | 1 | 2016 | 409 | 0.090 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 1 | 2012 | 28 | 0.090 |
Why?
| | Cluster Analysis | 1 | 2013 | 500 | 0.090 |
Why?
| | Family Health | 1 | 2012 | 191 | 0.090 |
Why?
| | Endoribonucleases | 2 | 2022 | 77 | 0.090 |
Why?
| | Chordata | 1 | 2011 | 5 | 0.090 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2023 | 1149 | 0.080 |
Why?
| | Gene Dosage | 1 | 2011 | 145 | 0.080 |
Why?
| | Retroviridae Infections | 2 | 2009 | 47 | 0.080 |
Why?
| | DNA Polymerase beta | 1 | 2010 | 6 | 0.080 |
Why?
| | Biomarkers, Tumor | 3 | 2022 | 1321 | 0.080 |
Why?
| | Endonucleases | 1 | 2010 | 34 | 0.080 |
Why?
| | Hospitalization | 1 | 2021 | 2460 | 0.080 |
Why?
| | Iron | 1 | 2013 | 357 | 0.080 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 371 | 0.080 |
Why?
| | Multicenter Studies as Topic | 2 | 2022 | 412 | 0.080 |
Why?
| | Endodeoxyribonucleases | 1 | 2010 | 77 | 0.080 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2010 | 55 | 0.080 |
Why?
| | Lung | 1 | 2023 | 4106 | 0.080 |
Why?
| | Gene Conversion | 1 | 1989 | 7 | 0.080 |
Why?
| | Vero Cells | 2 | 2019 | 83 | 0.070 |
Why?
| | Genetic Techniques | 1 | 1989 | 66 | 0.070 |
Why?
| | Fetal Growth Retardation | 1 | 2015 | 593 | 0.070 |
Why?
| | Rodentia | 1 | 2009 | 61 | 0.070 |
Why?
| | Statistics as Topic | 1 | 1989 | 283 | 0.070 |
Why?
| | Estrogens | 1 | 2011 | 367 | 0.070 |
Why?
| | Pregnancy | 1 | 2021 | 7202 | 0.070 |
Why?
| | Survival Rate | 1 | 2013 | 2090 | 0.070 |
Why?
| | Chromosome Deletion | 2 | 2021 | 126 | 0.070 |
Why?
| | Reverse Transcription | 1 | 2007 | 20 | 0.070 |
Why?
| | Retrospective Studies | 4 | 2025 | 17291 | 0.070 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2007 | 47 | 0.070 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3542 | 0.060 |
Why?
| | Binding Sites | 1 | 2010 | 1310 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2025 | 1747 | 0.060 |
Why?
| | Minichromosome Maintenance Proteins | 2 | 2004 | 6 | 0.060 |
Why?
| | Genetics, Population | 2 | 2006 | 217 | 0.060 |
Why?
| | Adaptation, Physiological | 1 | 2010 | 560 | 0.060 |
Why?
| | Meiosis | 1 | 2006 | 101 | 0.060 |
Why?
| | Genomic Instability | 1 | 2006 | 67 | 0.060 |
Why?
| | Students | 2 | 2023 | 651 | 0.060 |
Why?
| | Cattle | 1 | 2007 | 946 | 0.060 |
Why?
| | Point Mutation | 2 | 2018 | 240 | 0.050 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2004 | 20 | 0.050 |
Why?
| | vif Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 3 | 0.050 |
Why?
| | APOBEC-1 Deaminase | 1 | 2004 | 5 | 0.050 |
Why?
| | APOBEC-3G Deaminase | 1 | 2004 | 5 | 0.050 |
Why?
| | Gene Products, vif | 1 | 2004 | 2 | 0.050 |
Why?
| | APOBEC Deaminases | 1 | 2004 | 6 | 0.050 |
Why?
| | Cats | 2 | 2019 | 231 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1996 | 0.050 |
Why?
| | RNA Editing | 1 | 2004 | 26 | 0.050 |
Why?
| | Limb Deformities, Congenital | 1 | 2024 | 22 | 0.050 |
Why?
| | Phosphotransferases | 1 | 2024 | 26 | 0.050 |
Why?
| | Genomic Structural Variation | 1 | 2024 | 13 | 0.050 |
Why?
| | Muscle Hypotonia | 1 | 2024 | 33 | 0.050 |
Why?
| | Minichromosome Maintenance Complex Component 7 | 2 | 2000 | 4 | 0.050 |
Why?
| | Likelihood Functions | 1 | 2004 | 138 | 0.050 |
Why?
| | rab5 GTP-Binding Proteins | 1 | 2023 | 10 | 0.050 |
Why?
| | Catalysis | 1 | 2004 | 305 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2003 | 123 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2024 | 397 | 0.050 |
Why?
| | Plant Viruses | 1 | 2003 | 12 | 0.050 |
Why?
| | rab GTP-Binding Proteins | 1 | 2023 | 76 | 0.050 |
Why?
| | Sequence Deletion | 1 | 2003 | 190 | 0.050 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2004 | 237 | 0.050 |
Why?
| | Muscle Proteins | 1 | 2004 | 242 | 0.050 |
Why?
| | Neuroblastoma | 1 | 2024 | 174 | 0.050 |
Why?
| | Monkeypox virus | 1 | 2022 | 23 | 0.050 |
Why?
| | Genetic Markers | 1 | 2003 | 335 | 0.050 |
Why?
| | Risk Factors | 3 | 2012 | 10885 | 0.050 |
Why?
| | Masks | 1 | 2023 | 70 | 0.050 |
Why?
| | Focus Groups | 1 | 2025 | 569 | 0.040 |
Why?
| | Cytoplasm | 1 | 2022 | 254 | 0.040 |
Why?
| | Arachis | 1 | 2003 | 108 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 749 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 129 | 0.040 |
Why?
| | Neuroimaging | 1 | 2023 | 297 | 0.040 |
Why?
| | Minichromosome Maintenance Complex Component 4 | 1 | 2000 | 1 | 0.040 |
Why?
| | Minichromosome Maintenance Complex Component 3 | 1 | 2000 | 2 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2024 | 611 | 0.040 |
Why?
| | Attitude | 1 | 2023 | 259 | 0.040 |
Why?
| | Haploinsufficiency | 1 | 2021 | 54 | 0.040 |
Why?
| | Oligopeptides | 1 | 2022 | 267 | 0.040 |
Why?
| | Computer Simulation | 1 | 2025 | 1003 | 0.040 |
Why?
| | Dimerization | 1 | 2000 | 189 | 0.040 |
Why?
| | B-Lymphocytes | 1 | 2006 | 870 | 0.040 |
Why?
| | Knowledge Bases | 1 | 2020 | 28 | 0.040 |
Why?
| | Geminiviridae | 1 | 1999 | 1 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2023 | 326 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2022 | 260 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2000 | 234 | 0.040 |
Why?
| | DNA Copy Number Variations | 1 | 2020 | 184 | 0.040 |
Why?
| | Histone Acetyltransferases | 1 | 2020 | 57 | 0.040 |
Why?
| | Flavivirus | 1 | 2019 | 19 | 0.040 |
Why?
| | Cloning, Molecular | 2 | 2011 | 538 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2022 | 419 | 0.040 |
Why?
| | HeLa Cells | 1 | 2000 | 632 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2025 | 867 | 0.040 |
Why?
| | Philippines | 1 | 2018 | 51 | 0.040 |
Why?
| | Zebrafish | 1 | 2023 | 532 | 0.040 |
Why?
| | Skull | 1 | 2020 | 162 | 0.040 |
Why?
| | Nucleotides, Cyclic | 1 | 2018 | 22 | 0.030 |
Why?
| | Proteolysis | 1 | 2019 | 172 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2019 | 387 | 0.030 |
Why?
| | Genes, Recessive | 1 | 2018 | 78 | 0.030 |
Why?
| | DNA Replication | 1 | 2000 | 249 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 2121 | 0.030 |
Why?
| | Age Distribution | 1 | 2018 | 403 | 0.030 |
Why?
| | Capsid Proteins | 2 | 2012 | 94 | 0.030 |
Why?
| | Encephalitis, Viral | 1 | 1997 | 45 | 0.030 |
Why?
| | Immunotherapy | 1 | 2022 | 666 | 0.030 |
Why?
| | Developing Countries | 1 | 2019 | 316 | 0.030 |
Why?
| | Herpes Simplex | 1 | 1997 | 99 | 0.030 |
Why?
| | Langer-Giedion Syndrome | 1 | 2016 | 2 | 0.030 |
Why?
| | Hair Diseases | 1 | 2016 | 10 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1891 | 0.030 |
Why?
| | Cycloheximide | 1 | 2015 | 42 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 679 | 0.030 |
Why?
| | Nose | 1 | 2016 | 67 | 0.030 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2016 | 66 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2019 | 499 | 0.030 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2015 | 48 | 0.030 |
Why?
| | Methyltransferases | 1 | 2016 | 75 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 242 | 0.030 |
Why?
| | Codon | 1 | 2015 | 92 | 0.030 |
Why?
| | Guanylate Kinases | 1 | 2015 | 13 | 0.030 |
Why?
| | Fingers | 1 | 2016 | 107 | 0.030 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2015 | 28 | 0.030 |
Why?
| | Tooth, Deciduous | 1 | 2015 | 19 | 0.030 |
Why?
| | Methionine | 1 | 2016 | 161 | 0.030 |
Why?
| | Incisor | 1 | 2015 | 22 | 0.030 |
Why?
| | Genome, Mitochondrial | 1 | 2015 | 26 | 0.030 |
Why?
| | Dental Enamel | 1 | 2015 | 67 | 0.030 |
Why?
| | Population Surveillance | 1 | 2018 | 484 | 0.030 |
Why?
| | Archaeology | 1 | 2015 | 36 | 0.030 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2015 | 56 | 0.030 |
Why?
| | RNA, Transfer | 1 | 2015 | 143 | 0.030 |
Why?
| | Thyroid Gland | 1 | 2015 | 89 | 0.030 |
Why?
| | Paresis | 1 | 2014 | 30 | 0.030 |
Why?
| | Deoxyribonucleotides | 1 | 2014 | 20 | 0.030 |
Why?
| | Myopathies, Structural, Congenital | 1 | 2014 | 4 | 0.030 |
Why?
| | SAM Domain and HD Domain-Containing Protein 1 | 1 | 2014 | 12 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2015 | 305 | 0.030 |
Why?
| | Diaphragm | 1 | 2014 | 48 | 0.030 |
Why?
| | Nucleosomes | 1 | 2016 | 163 | 0.030 |
Why?
| | Interferon-gamma | 1 | 1997 | 784 | 0.030 |
Why?
| | Machine Learning | 1 | 2020 | 587 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2018 | 3124 | 0.030 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2014 | 32 | 0.030 |
Why?
| | Financing, Organized | 1 | 2014 | 36 | 0.030 |
Why?
| | DNA, Mitochondrial | 1 | 2015 | 211 | 0.020 |
Why?
| | Uterus | 1 | 2015 | 227 | 0.020 |
Why?
| | Lysine | 1 | 2016 | 305 | 0.020 |
Why?
| | Prognosis | 1 | 2022 | 4316 | 0.020 |
Why?
| | Cytokines | 1 | 2021 | 2067 | 0.020 |
Why?
| | Time Factors | 1 | 2004 | 7123 | 0.020 |
Why?
| | RING Finger Domains | 1 | 2013 | 4 | 0.020 |
Why?
| | Brain Diseases | 1 | 2014 | 155 | 0.020 |
Why?
| | Rats | 2 | 2014 | 5584 | 0.020 |
Why?
| | Meta-Analysis as Topic | 1 | 2014 | 171 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2026 | 6066 | 0.020 |
Why?
| | Loss of Heterozygosity | 1 | 2013 | 52 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1963 | 0.020 |
Why?
| | Risk | 1 | 2015 | 919 | 0.020 |
Why?
| | Transferrin | 1 | 2012 | 50 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 1992 | 23 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 302 | 0.020 |
Why?
| | CHO Cells | 1 | 2012 | 169 | 0.020 |
Why?
| | Motor Neurons | 1 | 2014 | 236 | 0.020 |
Why?
| | Penetrance | 1 | 2011 | 30 | 0.020 |
Why?
| | Cricetinae | 1 | 2012 | 305 | 0.020 |
Why?
| | Erythropoiesis | 1 | 1992 | 57 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2012 | 219 | 0.020 |
Why?
| | Aromatase | 1 | 2011 | 35 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5904 | 0.020 |
Why?
| | Erythropoietin | 1 | 1992 | 100 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2011 | 273 | 0.020 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 5983 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2016 | 1443 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4148 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2011 | 486 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 1989 | 152 | 0.020 |
Why?
| | Apoptosis | 1 | 1997 | 2440 | 0.020 |
Why?
| | Models, Statistical | 2 | 2004 | 671 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 2524 | 0.020 |
Why?
| | Neurons | 1 | 1997 | 1649 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2011 | 401 | 0.020 |
Why?
| | Hematopoietic Stem Cells | 1 | 1992 | 435 | 0.020 |
Why?
| | Family | 1 | 2013 | 682 | 0.020 |
Why?
| | Comorbidity | 1 | 2011 | 1661 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2006 | 43 | 0.010 |
Why?
| | Heart Defects, Congenital | 1 | 2014 | 910 | 0.010 |
Why?
| | Escherichia coli | 1 | 1989 | 835 | 0.010 |
Why?
| | Aged | 2 | 2015 | 26153 | 0.010 |
Why?
| | Africa, Western | 1 | 2003 | 21 | 0.010 |
Why?
| | Cohort Studies | 1 | 2014 | 6013 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 1989 | 967 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2015 | 8333 | 0.010 |
Why?
| | India | 1 | 2003 | 213 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2003 | 244 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2003 | 130 | 0.010 |
Why?
| | Sample Size | 1 | 2001 | 121 | 0.010 |
Why?
| | Sweden | 1 | 2001 | 115 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2001 | 272 | 0.010 |
Why?
| | Two-Hybrid System Techniques | 1 | 2000 | 59 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2000 | 123 | 0.010 |
Why?
| | G1 Phase | 1 | 2000 | 65 | 0.010 |
Why?
| | Gene Deletion | 1 | 2001 | 391 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 373 | 0.010 |
Why?
| | Temperature | 1 | 2000 | 633 | 0.010 |
Why?
| | Cell Cycle | 1 | 2000 | 598 | 0.010 |
Why?
| | Antigens, Viral | 1 | 1997 | 182 | 0.010 |
Why?
| | Interleukin-4 | 1 | 1997 | 207 | 0.010 |
Why?
| | Eye | 1 | 1997 | 112 | 0.010 |
Why?
| | Chromatin | 1 | 2000 | 553 | 0.010 |
Why?
| | Defective Viruses | 1 | 1992 | 5 | 0.010 |
Why?
| | Interleukin-3 | 1 | 1992 | 23 | 0.010 |
Why?
| | Receptors, Erythropoietin | 1 | 1992 | 21 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 1992 | 93 | 0.010 |
Why?
| | Fluorouracil | 1 | 1992 | 231 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1992 | 666 | 0.000 |
Why?
| | Inflammation | 1 | 1997 | 2878 | 0.000 |
Why?
|
|
Sawyer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|